Evidence map›Paper›PMID 36344525›Full record

ArticleNature communications2022

SAMHD1 deacetylation by SIRT1 promotes DNA end resection by facilitating DNA binding at double-strand breaks.

Priya Kapoor-Vazirani, Sandip K Rath, Xu Liu, Zhen Shu, Nicole E Bowen, Yitong Chen, Ramona Haji-Seyed-Javadi, Waaqo Daddacha, Elizabeth V Minten, Diana Danelia and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 25 citations in OpenAlex.

  1. EradicatingBioactive materials · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Transcriptomic Analysis Reveals Key Pathways Influenced by HIV-2 Vpx.International journal of molecular sciences · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Priya Kapoor-VaziraniDepartment of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Sandip K RathDepartment of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Xu LiuDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Zhen ShuDepartment of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Nicole E BowenDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, 30322, USA.ORCID 0000-0003-4269-2167
Yitong ChenDepartment of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Ramona Haji-Seyed-JavadiDepartment of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Waaqo DaddachaDepartment of Biochemistry and Molecular Biology, Medical College of Georgia at Augusta University, Augusta, GA, 30912, USA.
Elizabeth V MintenDepartment of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Diana DaneliaDepartment of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA.ORCID 0000-0001-6994-9511
Daniela FarchiDepartment of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Duc M DuongDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Nicholas T SeyfriedDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA, 30322, USA.ORCID 0000-0002-4507-624X
Xingming DengDepartment of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Eric A OrtlundDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA, 30322, USA.ORCID 0000-0001-8855-3029
Baek KimDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, 30322, USA.ORCID 0000-0001-7986-4335
David S YuDepartment of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA. dsyu@emory.edu.ORCID 0000-0002-2781-5379
Emory University · USAugusta University · US

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
Project 3: Targeting Bax signaling to overcome treatment resistance in NSCLCP50CA217691 · NCI · EMORY UNIVERSITY · PI SICA, GABRIEL LARKIN · 2019 to 2024
$10.1M
Lentivirus Replication Strategy and PathogenesisR01AI136581 · NIAID · EMORY UNIVERSITY · PI Baek Kim · 2018 to 2026
$3.9M
Mechanisms of SIRT2 Function in the Replication Stress ResponseR01CA178999 · NCI · EMORY UNIVERSITY · PI YU, DAVID SUNG-WEN · 2013 to 2023
$3.5M
Elucidating SAMHD1 in DNA Double-Strand Break Repair (Supplement)R01CA254403 · NCI · EMORY UNIVERSITY · PI KIM, BAEK, YU, DAVID SUNG-WEN · 2020 to 2024
$2.9M
SAMHD1 mediated dNTP regulation and HIV in myeloid cellsR01AI162633 · NIAID · EMORY UNIVERSITY · PI Baek Kim · 2021 to 2026
$2.7M
Modulation of Mcl-1 for Treatment of Lung CancerR01CA255257 · NCI · EMORY UNIVERSITY · PI DENG, XINGMING · 2021 to 2025
$2.1M
Understanding mechanistic role of SAMHD1 in DNA damage response and therapeutic benefit for malignant gliomaK01CA226346 · NCI · EMORY UNIVERSITY · PI DADDACHA, WAAQO BORU · 2018 to 2022
$549k
Defining a common mechanism of SAMHD1 function in cancer, HIV, and AGSF31AI157884 · NIAID · EMORY UNIVERSITY · PI BOWEN, NICOLE EILEEN · 2021 to 2022
$86k
NCI NIH HHS K01 CA226346NCI NIH HHS P30 CA138292NCI NIH HHS P50 CA217691NCI NIH HHS R01 CA178999NCI NIH HHS R01 CA254403NCI NIH HHS R01 CA255257NIAID NIH HHS F31 AI157884NIAID NIH HHS R01 AI136581NIAID NIH HHS R01 AI162633U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA178999U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA254403
6 · The paper itself

Abstract

Sterile alpha motif and HD domain-containing protein 1 (SAMHD1) has a dNTPase-independent function in promoting DNA end resection to facilitate DNA double-strand break (DSB) repair by homologous recombination (HR); however, it is not known if upstream signaling events govern this activity. Here, we show that SAMHD1 is deacetylated by the SIRT1 sirtuin deacetylase, facilitating its binding with ssDNA at DSBs, to promote DNA end resection and HR. SIRT1 complexes with and deacetylates SAMHD1 at conserved lysine 354 (K354) specifically in response to DSBs. K354 deacetylation by SIRT1 promotes DNA end resection and HR but not SAMHD1 tetramerization or dNTPase activity. Mechanistically, K354 deacetylation by SIRT1 promotes SAMHD1 recruitment to DSBs and binding to ssDNA at DSBs, which in turn facilitates CtIP ssDNA binding, leading to promotion of genome integrity. These findings define a mechanism governing the dNTPase-independent resection function of SAMHD1 by SIRT1 deacetylation in promoting HR and genome stability.

Indexed as

DNA Breaks, Double-StrandedSirtuin 1DNADNA RepairDNA, Single-StrandedHomologous RecombinationDNADNA, Single-StrandedSirtuin 1

Identifiers

PMID36344525
PMCPMC9640623
OpenAlexW4308766722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.